Imaging Core Lab for Madrigal Protocol MGL-3196-05 (A Phase 2, Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis)
Research Grant
Administered By
Radiology, Abdominal Imaging
Awarded By
Madrigal Pharmaceuticals
Start Date
February 19, 2019
End Date
January 31, 2023
Administered By
Radiology, Abdominal Imaging
Awarded By
Madrigal Pharmaceuticals
Start Date
February 19, 2019
End Date
January 31, 2023